Neuland Laboratories Limited (NEULANDLAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Neuland Laboratories Limited (NEULANDLAB) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-367.47 Million ≈ $-3.97 Million USD) by net assets (Rs16.20 Billion ≈ $175.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NEULANDLAB market cap for the company's overall valuation and market capitalisation.
Neuland Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2026)
This chart illustrates how Neuland Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Neuland Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuland Laboratories Limited ranked by their cash flow conversion efficiency. Explore earnings quality score of Neuland Laboratories Limited to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hefei Chipmore Technology Co. Ltd. A
SHG:688352
|
N/A |
|
Kadant Inc
NYSE:KAI
|
0.069x |
|
Jiangsu Yangnong Chemical Co Ltd
SHG:600486
|
0.033x |
|
Tongcheng Travel Holdings Ltd
F:TEM
|
0.017x |
|
Hyundai Steel
KO:004020
|
0.013x |
|
HSBC Holdings PLC
LSE:HSBA
|
0.002x |
|
Shanghai Xinmei Real Estate Co Ltd Class A
SHG:600732
|
-0.011x |
|
CVR Energy Inc
NYSE:CVI
|
0.413x |
Annual Cash Flow Conversion Efficiency for Neuland Laboratories Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of Neuland Laboratories Limited from 2006 to 2026. View Neuland Laboratories Limited stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs18.74 Billion ≈ $202.72 Million |
Rs3.38 Billion ≈ $36.58 Million |
0.180x | -13.31% |
| 2025-03-31 | Rs15.25 Billion ≈ $164.90 Million |
Rs3.17 Billion ≈ $34.32 Million |
0.208x | +4.42% |
| 2024-03-31 | Rs12.83 Billion ≈ $138.72 Million |
Rs2.56 Billion ≈ $27.65 Million |
0.199x | -16.93% |
| 2023-03-31 | Rs9.94 Billion ≈ $107.51 Million |
Rs2.39 Billion ≈ $25.80 Million |
0.240x | +244.27% |
| 2022-03-31 | Rs8.41 Billion ≈ $90.90 Million |
Rs585.81 Million ≈ $6.34 Million |
0.070x | -71.05% |
| 2021-03-31 | Rs7.86 Billion ≈ $85.05 Million |
Rs1.89 Billion ≈ $20.48 Million |
0.241x | +198.11% |
| 2020-03-31 | Rs7.10 Billion ≈ $76.78 Million |
Rs573.41 Million ≈ $6.20 Million |
0.081x | -19.21% |
| 2019-03-31 | Rs6.99 Billion ≈ $75.63 Million |
Rs699.07 Million ≈ $7.56 Million |
0.100x | +395.08% |
| 2018-03-31 | Rs5.58 Billion ≈ $60.35 Million |
Rs112.68 Million ≈ $1.22 Million |
0.020x | -71.52% |
| 2017-03-31 | Rs5.46 Billion ≈ $59.01 Million |
Rs386.81 Million ≈ $4.18 Million |
0.071x | -70.48% |
| 2016-03-31 | Rs1.87 Billion ≈ $20.18 Million |
Rs448.26 Million ≈ $4.85 Million |
0.240x | +194.71% |
| 2015-03-31 | Rs1.62 Billion ≈ $17.48 Million |
Rs131.72 Million ≈ $1.42 Million |
0.081x | -77.18% |
| 2014-03-31 | Rs1.24 Billion ≈ $13.44 Million |
Rs443.82 Million ≈ $4.80 Million |
0.357x | +39.32% |
| 2013-03-31 | Rs1.00 Billion ≈ $10.83 Million |
Rs256.77 Million ≈ $2.78 Million |
0.256x | -60.26% |
| 2012-03-31 | Rs764.81 Million ≈ $8.27 Million |
Rs493.39 Million ≈ $5.34 Million |
0.645x | +39.53% |
| 2011-03-31 | Rs739.68 Million ≈ $8.00 Million |
Rs341.98 Million ≈ $3.70 Million |
0.462x | +109.13% |
| 2010-03-31 | Rs688.95 Million ≈ $7.45 Million |
Rs152.31 Million ≈ $1.65 Million |
0.221x | -22.15% |
| 2009-03-31 | Rs758.08 Million ≈ $8.20 Million |
Rs215.28 Million ≈ $2.33 Million |
0.284x | +186.68% |
| 2008-03-31 | Rs686.76 Million ≈ $7.43 Million |
Rs68.03 Million ≈ $735.72K |
0.099x | +218.14% |
| 2007-03-31 | Rs596.77 Million ≈ $6.45 Million |
Rs-50.04 Million ≈ $-541.16K |
-0.084x | -151.12% |
| 2006-03-31 | Rs523.07 Million ≈ $5.66 Million |
Rs85.81 Million ≈ $927.97K |
0.164x | -- |
About Neuland Laboratories Limited
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.